MCP and Cancer Therapy
Conventional cancer treatment involves surgery to remove primary tumors, followed by chemotherapy, radiation, or a combination of treatments designed to eradicate all remaining traces of cancer. This follow-up therapy is critical for addressing the biggest threat from cancer - the formation of secondary cancers, or metastases. Metastases are not new or different cancers, but rather new cancer colonies started from primary cancer cells that have migrated to new sites. Sites where metastases commonly occur include the bones, lungs, prostate, kidney, liver, thyroid and brain. Left unchecked, metastases can quickly overwhelm the body's defenses. In fact, it is metastases, not primary tumors that are responsible for most cancer deaths.
Scientists used to think cancer cells were individual actors, and that even a single cell escaping from the main tumor would likely start a new colony elsewhere in the body. But now we know that cancer growth is more of a "group activity". Just as a platoon of soldiers is more powerful than a single rifleman, cancer cells are more dangerous when they assemble and clump together. To do this, they must communicate with and bind to one another. That cell-to-cell interaction is made possible by special protein molecules called galectins that sit on the outer surfaces of the cancer cells.
After a cancer cell has broken free from its primary tumor (or is accidentally dislodged during surgery) it floats freely through the blood and lymph systems until it eventually becomes trapped in a small blood vessel (microcapillary). Firmly lodged in the microcapillary, galectins on the surface of the cancer cell start to bind to galactose receptors on endothelial cells (the cells that form the inside lining of blood vessels). After securely attaching to the endothelium, the cancer cells penetrate through and invade the blood vessel walls. The final step in establishing a new tumor colony is the release of chemical signals that trigger new blood vessel growth (angiogenesis). The new blood vessels will supply the cancer cells with the nutrients they need to grow and thrive.
The powerful attraction between galectins and galactose plays a pivotal role in MCP cancer therapy. Galectins and galactoses work much like a car's key and ignition. Only the correct key will fit into the ignition and activate the engine. Other keys may "fit", but they will not "fit" quite right - they will only jam the ignition and prevent it from working. Galactose rich MPC has a strong binding affinity for galectins and being the "wrong key" has the ability to jam up the "molecular ignition", preventing the right key from getting in. With their molecular ignitions jammed, cancer cells find it harder to stick to other cancer cells or to healthy tissues. In short, they are rendered less likely to metastasize. MCP has the additional effect of blocking angiogenesis which results in the cancer cells being starved to death.
Of all diseases, MCP has been studied most extensively for prostate cancer, one of the most common cancers in men. MCP has been shown to slow PSA doubling time, to stop the spread of prostate cancer, and kill prostate cancer cells
Click Here to read more about research on Modified Citrus Pectin as a Cancer therapy.
Garlic and Cancer Therapy
Garlic is known to have anti-tumor properties, owing to its content of a wide variety of organic sulfides and polysulfides, which disrupt the metabolism of tumor cells. This inhibition seems to be most effective when the tumor is small. It is theorized that garlic enhances immune function by stimulating lymphocytes and macrophages to destroy cancer cells. Additinoally, garlic inhibits the formation of both nitrosamines (potent carcinogens) and DNA adducts.
Various studies have shown that garlic can slow the development of bladder, skin, stomach, and colon cancers. In the United States, the Iowa Women's Health Study--an ongoing Iowa State University diet and health study of nearly 35,000 women aged 55 to 69--found that people who eat garlic at least once a week have a significantly lower risk of colon cancer:
Recent studies have also shown that garlic destroys H. pylori, the bacteria believed to cause some stomach ulcers and a suspected culprit in stomach cancer. Population studies in China and Italy found that the incidence of stomach cancer is lower in people who eat lots of garlic.
Cilantro and Cancer Therapy
In that detoxificatin is a major componant to a cancer therapy, cilantro being such a good detoxifier should be part of any cancer therapy program.